North America’s medical devices industry saw a drop of 25.66% in deal activity during April 2022, when compared with the last 12-month average, led by ArchiMed’s $1.2bn private equity deal with Natus Medical , according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 84 medical devices industry deals worth $2.8bn were announced for the region in April 2022, against the 12-month average of 113 deals.
Of all the deal types, venture financing saw most activity in April 2022 with 65 transactions, representing a 77.4% share for the region.
In second place was M&A with 16 deals, followed by private equity deals with three transactions, respectively capturing a 19.05% and 3.6% share of the overall deal activity for the month.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $1.27bn, while private equity and M&A deals totalled $1.2bn and $334.7m, respectively.
North America medical devices industry deals in April 2022: Top deals
The top five medical devices deals accounted for 72.9% of the overall value during April 2022.
The combined value of the top five medical devices deals stood at $2.04bn, against the overall value of $2.8bn recorded for the month.
The top five medical devices industry deals of April 2022 tracked by GlobalData were:
1) ArchiMed $1.2bn private equity deal with Natus Medical
3) Adams Street Partners,Altimeter Capital Management,Battery Ventures,Coatue,Dragoneer Investment Group and ICONIQ Growth $220m venture financing deal with Reify Health
5) Impact Investment Partners,Japan Industrial Partners and NEC $150m venture financing deal with BostonGene